Skip to main content

PharmacoEconomics

Ausgabe 3/2001

Inhalt (8 Artikel)

Leading Article

Influenza

Peter Cram, Susan G. Blitz, Arnold Monto, A. Mark Fendrick

Review Article

Workplace Productivity

Paul Stang, Roger Cady, Alice Batenhorst, Lynn Hoffman

Review Article

Economic Burden of Chronic Obstructive Pulmonary Disease

Mitchell Friedman, Daniel E. Hilleman

Original Research Article

Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries

Carlos Gouveia Pinto, Antoine Lafuma, Francis Fagnani, Mark J. C. Nuijten, Gilles Berdeaux

Original Research Article

Cost of Treatment for Onychomycosis

David M. Stier, Curt Henke, Jeff Schein, Joe Doyle, Warren H. Schonfeld, Jeanette Broering

Original Research Article

Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel

Gabriel Chodick, Yehuda Lerman, Tamar Peled, Hava Aloni, Shai Ashkenazi

Original Research Article

Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

Adrian D. Griffin, Andrew S. Perry, Douglas M. Fleming

Adis Pharmacoeconomic Drug Evaluation

Rivastigmine

Harriet M. Lamb, Karen L. Goa